The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
Ecology and Evolution of Cancer 2017
DOI: 10.1016/b978-0-12-804310-3.00010-7
|View full text |Cite
|
Sign up to set email alerts
|

The Response of Cancer Cell Populations to Therapies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 213 publications
0
1
0
Order By: Relevance
“…The vast majority of both current and under development therapies are directed toward killing or suppressing the proliferation of tumor cells. Despite the introduction of highly effective drugs, such as tyrosine kinase inhibitors of EGFR or ALK signaling pathways, our ability to eradicate tumors is limited by ITH in therapy sensitivity, where some tumor cells avoid elimination due to genetic, epigenetic, or microenvironmental differences (Lindsay et al, 2017 ). Development of complex combination therapy schedules that target multiple mechanisms of persistence and resistance operating within the same tumors is limited by availability of drugs and issues of systemic toxicities.…”
Section: Therapeutic Implicationsmentioning
confidence: 99%
“…The vast majority of both current and under development therapies are directed toward killing or suppressing the proliferation of tumor cells. Despite the introduction of highly effective drugs, such as tyrosine kinase inhibitors of EGFR or ALK signaling pathways, our ability to eradicate tumors is limited by ITH in therapy sensitivity, where some tumor cells avoid elimination due to genetic, epigenetic, or microenvironmental differences (Lindsay et al, 2017 ). Development of complex combination therapy schedules that target multiple mechanisms of persistence and resistance operating within the same tumors is limited by availability of drugs and issues of systemic toxicities.…”
Section: Therapeutic Implicationsmentioning
confidence: 99%